| GENENTA SCIENCE(SP.ADR)/1 |
| USA |
| Gesundheit |
| US36870W1009 / A3C9EK |
| K5F (Frankfurt) / GNTA (NASDAQ) |
| FRA:K5F, ETR:K5F, K5F:GR, NASDAQ:GNTA |
| - |
| https://www.genenta.com/ |
|
Genenta Science S.p.A. is a biotechnology company focused on developing innovative therapies for cancer treatment. As an emerging leader in the field of immuno-gene therapy, Genenta Science aims to harness the body's immune system to combat and eradi..
>Volltext.. |
| 11.56 Mio. EUR |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| GENENTA |
| 05.04.26 |
|